Dubai Investments, through its subsidiary Globalpharma, has signed Memorandum of Understanding (MoU) with Angola’s Ministry of Health to establish a pharmaceutical manufacturing facility in Dubai Investments Park (DIP) Angola.
The MoU follows the recent UAE delegation visit to Angola, led by His Highness Sheikh Mohamed bin Zayed Al Nahyan, President of the United Arab Emirates and Ruler of Abu Dhabi.
The Globalpharma manufacturing facility is expected to create hundreds of jobs, enhance healthcare self-sufficiency, and reduce reliance on imported medical products, a key milestone in strengthening Angola’s healthcare ecosystem.
The MoU was signed by Khalid Bin Kalban, Vice Chairman and CEO of Dubai Investments, and Dr. Nídia da Silva Jorge Saiundo, standing in representation for the Ministry of Health, Angola.
Khalid bin Kalban Vice Chairman & CEO Dubai Investments
“This agreement marks more than a partnership, it represents a shared vision for the future of Angola’s healthcare landscape. Dubai Investments believes that sustainable growth comes from empowering nations to unlock their own potential. By aligning with Angola’s ambitions to become a regional hub for healthcare, Dubai Investments is investing not just in a project through this facility in DIP Angola, but in the foundations of long-term healthcare prosperity.”
With over two decades of expertise, Globalpharma has established itself as a leading producer of high-quality generic and branded medicines across key therapeutic areas, including cardiovascular, anti-infective, gastrointestinal, and pain management.
The company’s state-of-the-art manufacturing facilities are cGMP-certified and approved by health authorities across the GCC, Levant, Africa, and CIS regions.
Hon. Sílvia Paula Valentim Lutucuta, Minister of Health of Angola commented that, “This collaboration with DIP Angola and Globalpharma will strengthen Angola’s local production of essential medicines, reinforcing our healthcare system and ensuring greater access to high- quality medical products. By boosting domestic manufacturing, we are advancing toward self-sufficiency and improving the resilience of our healthcare sector.”
The Ministry of Health will coordinate with relevant government bodies to expedite the issuance of licenses, permits, and regulatory approvals, as well as facilitate access to available tax incentives, exemptions, and investment benefits, in accordance with national laws and investment promotion regulations.
